The Board consists of 18 representative seats, 9 seats for independent or unaffiliated individuals, and 1 seat for Gavi's CEO. The representative seats on the Board ensure that institutions and constituencies have a formal platform to provide input into the development of Gavi's policies and the management of its operations.

The independent members of the Gavi Board are private individuals who have no professional association with Gavi's work. They offer impartial and objective evaluation to all the Board's discussions. Additionally, these individuals provide expertise in a number of crucial areas such as investment, auditing and fundraising.

Two thirds of the voting members of the Board are representatives from key Vaccine Alliance partner institutions and stakeholders (each such representative is a 'representative Board member'), and one third of its voting members are independent (or unaffiliated) individuals who are appointed in their personal capacity on the basis of their skills and networks.

Board members are responsible for choosing and appointing new Board members in accordance with the Statutes and Operating Procedures.

Alternate Board members

Each eligible organisation and constituency has the right to appoint one person as an 'Alternate Board member' for each elected Board member. Alternate Board members can act on behalf of the elected Board member if required. The appointment of the Alternate Board member follows the Operating Procedures and is subject to approval by existing Board members.

Both Board members and Alternate Board members are entitled to attend Board meetings. It is recommended that at least one attend, to ensure representation of their constituency.

Observers

In accordance with the Board and Board Committee Operating Procedures, observers who wish to attend either a Board meeting or a Committee meeting must obtain permission from the relevant Chair.

Documents

Last updated: 8 Oct 2024

Subscribe to our newsletter